Type III hyperlipoproteinemia: development of a VLDL ApoE gel isoelectric focusing technique and application in family studies. 1979

S W Weidman, and B Suarez, and J M Falko, and J L Witztum, and J Kolar, and M Raben, and G Schonfeld

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007525 Isoelectric Focusing Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point. Electrofocusing,Focusing, Isoelectric
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008297 Male Males
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D005260 Female Females
D005782 Gels Colloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquefies; the resulting colloid is called a sol.
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S W Weidman, and B Suarez, and J M Falko, and J L Witztum, and J Kolar, and M Raben, and G Schonfeld
February 1979, Clinical chemistry,
S W Weidman, and B Suarez, and J M Falko, and J L Witztum, and J Kolar, and M Raben, and G Schonfeld
July 1991, Clinical chemistry,
S W Weidman, and B Suarez, and J M Falko, and J L Witztum, and J Kolar, and M Raben, and G Schonfeld
January 1982, Polskie Archiwum Medycyny Wewnetrznej,
S W Weidman, and B Suarez, and J M Falko, and J L Witztum, and J Kolar, and M Raben, and G Schonfeld
January 1970, Analytical biochemistry,
S W Weidman, and B Suarez, and J M Falko, and J L Witztum, and J Kolar, and M Raben, and G Schonfeld
April 1971, Analytical biochemistry,
S W Weidman, and B Suarez, and J M Falko, and J L Witztum, and J Kolar, and M Raben, and G Schonfeld
January 1997, Journal of chromatography. A,
S W Weidman, and B Suarez, and J M Falko, and J L Witztum, and J Kolar, and M Raben, and G Schonfeld
July 1968, Nature,
S W Weidman, and B Suarez, and J M Falko, and J L Witztum, and J Kolar, and M Raben, and G Schonfeld
November 1982, Journal of lipid research,
S W Weidman, and B Suarez, and J M Falko, and J L Witztum, and J Kolar, and M Raben, and G Schonfeld
January 1972, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
S W Weidman, and B Suarez, and J M Falko, and J L Witztum, and J Kolar, and M Raben, and G Schonfeld
December 1971, Journal of chromatography,
Copied contents to your clipboard!